Nuria Tamayo
Amgen (United States)(US)Université Bourgogne Franche-Comté(FR)University of California, Davis(US)
Publications by Year
Research Areas
Cancer-related gene regulation, Bioactive Compounds and Antitumor Agents, Ion Channels and Receptors, Melanoma and MAPK Pathways, Microtubule and mitosis dynamics
Most-Cited Works
- → Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors(2019)691 cited
- → Pharmacological Blockade of the Cold Receptor TRPM8 Attenuates Autonomic and Behavioral Cold Defenses and Decreases Deep Body Temperature(2012)257 cited
- p38 MAP kinase inhibitors: many are made, but few are chosen.(2005)
- → Antihyperalgesic Effects of (R,E)-N-(2-Hydroxy-2,3-dihydro-1 H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a Novel Transient Receptor Potential Vanilloid Type 1 Modulator That Does Not Cause Hyperthermia in Rats(2008)160 cited
- → Revised Structures for the Kinamycin Antibiotics: 5-Diazobenzo[b]fluorenes Rather Than Benzo[b]carbazole Cyanamides(1994)115 cited
- → Palladium-catalyzed coupling of 2-bromonaphthoquinones with stannanes: a concise synthesis of antibiotics WS 5995 A and C and related compounds(1991)80 cited